Drug Shortage Report for IMITREX

Last updated on 2019-03-05 History
Report ID 74251
Drug Identification Number 02212188
Brand name IMITREX
Common or Proper name Sumatriptan succinate injection
Company Name GLAXOSMITHKLINE INC
Market Status MARKETED
Active Ingredient(s) SUMATRIPTAN
Strength(s) 12MG
Dosage form(s) LIQUID
Route of administration SUBCUTANEOUS
Packaging size 2x0.5mL
ATC code N02CC
ATC description ANTIMIGRAINE PREPARATIONS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2019-02-27
Estimated end date 2019-03-14
Actual end date 2019-03-04
Shortage status Resolved
Updated date 2019-03-05
Company comments
Health Canada comments
Tier 3 Status No
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v14 2019-03-05 French Compare
v13 2019-03-05 English Compare
v12 2019-03-05 English Compare
v11 2019-03-04 English Compare
v10 2019-02-28 English Compare
v9 2019-02-27 French Compare
v8 2019-02-27 English Compare
v7 2019-02-22 French Compare
v6 2019-02-22 English Compare
v5 2019-02-19 French Compare
v4 2019-02-19 English Compare
v3 2019-02-15 English Compare
v2 2019-02-01 French Compare
v1 2019-02-01 English Compare

Showing 1 to 14 of 14